First Time Loading...
B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 4.55 USD -3.19% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of muscul... [ Read More ]

The intrinsic value of one BVS stock under the Base Case scenario is 11.11 USD. Compared to the current market price of 4.55 USD, Bioventus Inc is Undervalued by 59%.

Key Points:
BVS Intrinsic Value
Base Case
11.11 USD
Undervaluation 59%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bioventus Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BVS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bioventus Inc

Provide an overview of the primary business activities
of Bioventus Inc.

What unique competitive advantages
does Bioventus Inc hold over its rivals?

What risks and challenges
does Bioventus Inc face in the near future?

Has there been any significant insider trading activity
in Bioventus Inc recently?

Summarize the latest earnings call
of Bioventus Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioventus Inc.

Provide P/S
for Bioventus Inc.

Provide P/E
for Bioventus Inc.

Provide P/OCF
for Bioventus Inc.

Provide P/FCFE
for Bioventus Inc.

Provide P/B
for Bioventus Inc.

Provide EV/S
for Bioventus Inc.

Provide EV/GP
for Bioventus Inc.

Provide EV/EBITDA
for Bioventus Inc.

Provide EV/EBIT
for Bioventus Inc.

Provide EV/OCF
for Bioventus Inc.

Provide EV/FCFF
for Bioventus Inc.

Provide EV/IC
for Bioventus Inc.

Show me price targets
for Bioventus Inc made by professional analysts.

What are the Revenue projections
for Bioventus Inc?

How accurate were the past Revenue estimates
for Bioventus Inc?

What are the Net Income projections
for Bioventus Inc?

How accurate were the past Net Income estimates
for Bioventus Inc?

What are the EPS projections
for Bioventus Inc?

How accurate were the past EPS estimates
for Bioventus Inc?

What are the EBIT projections
for Bioventus Inc?

How accurate were the past EBIT estimates
for Bioventus Inc?

Compare the revenue forecasts
for Bioventus Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioventus Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioventus Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioventus Inc compared to its peers.

Compare the P/E ratios
of Bioventus Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioventus Inc with its peers.

Analyze the financial leverage
of Bioventus Inc compared to its main competitors.

Show all profitability ratios
for Bioventus Inc.

Provide ROE
for Bioventus Inc.

Provide ROA
for Bioventus Inc.

Provide ROIC
for Bioventus Inc.

Provide ROCE
for Bioventus Inc.

Provide Gross Margin
for Bioventus Inc.

Provide Operating Margin
for Bioventus Inc.

Provide Net Margin
for Bioventus Inc.

Provide FCF Margin
for Bioventus Inc.

Show all solvency ratios
for Bioventus Inc.

Provide D/E Ratio
for Bioventus Inc.

Provide D/A Ratio
for Bioventus Inc.

Provide Interest Coverage Ratio
for Bioventus Inc.

Provide Altman Z-Score Ratio
for Bioventus Inc.

Provide Quick Ratio
for Bioventus Inc.

Provide Current Ratio
for Bioventus Inc.

Provide Cash Ratio
for Bioventus Inc.

What is the historical Revenue growth
over the last 5 years for Bioventus Inc?

What is the historical Net Income growth
over the last 5 years for Bioventus Inc?

What is the current Free Cash Flow
of Bioventus Inc?

Financials

Balance Sheet Decomposition
Bioventus Inc

Current Assets 249.5m
Cash & Short-Term Investments 26.8m
Receivables 112.9m
Other Current Assets 109.8m
Non-Current Assets 561.6m
Long-Term Investments 6.9m
PP&E 54m
Intangibles 500.8m
Other Non-Current Assets -100k
Current Liabilities 160.8m
Accounts Payable 17.6m
Accrued Liabilities 118.2m
Other Current Liabilities 25m
Non-Current Liabilities 472.8m
Long-Term Debt 375m
Other Non-Current Liabilities 97.8m
Efficiency

Earnings Waterfall
Bioventus Inc

Revenue
502.8m USD
Cost of Revenue
-186.7m USD
Gross Profit
316.1m USD
Operating Expenses
-337.9m USD
Operating Income
-21.8m USD
Other Expenses
-160.3m USD
Net Income
-182.1m USD

Free Cash Flow Analysis
Bioventus Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BVS Profitability Score
Profitability Due Diligence

Bioventus Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative Free Cash Flow
Positive Revenue Growth Forecast
36/100
Profitability
Score

Bioventus Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

BVS Solvency Score
Solvency Due Diligence

Bioventus Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
35/100
Solvency
Score

Bioventus Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVS Price Targets Summary
Bioventus Inc

Wall Street analysts forecast BVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVS is 8.16 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

Lowest
Price Target
7.07 USD
55% Upside
Average
Price Target
8.16 USD
79% Upside
Highest
Price Target
9.45 USD
108% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BVS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BVS Price
Bioventus Inc

1M 1M
-21%
6M 6M
+50%
1Y 1Y
+360%
3Y 3Y
-70%
5Y 5Y
-76%
10Y 10Y
-76%
Annual Price Range
4.55
52w Low
0.93
52w High
5.75
Price Metrics
Average Annual Return -52.77%
Standard Deviation of Annual Returns 41.78%
Max Drawdown -95%
Shares Statistics
Market Capitalization 287.1m USD
Shares Outstanding 63 101 172
Percentage of Shares Shorted 2%

BVS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Bioventus Inc

Country

United States of America

Industry

Health Care

Market Cap

287.1m USD

Dividend Yield

0%

Description

Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. The company is headquartered in Durham, North Carolina and currently employs 1,200 full-time employees. The company went IPO on 2021-02-11. The firm is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.

Contact

NORTH CAROLINA
Durham
4721 Emperor Boulevard, Suite 100
+19194746700.0
http://www.bioventus.com/

IPO

2021-02-11

Employees

1 200

Officers

Senior VP & CFO
Mr. Mark L. Singleton
President, CEO & Director
Mr. Robert Claypoole
Senior Vice President of Operations
Mr. Mike Crowe B.S., M.B.A.
Vice President of Investor Relations & Treasurer
Mr. David Crawford
Senior VP, General Counsel & Corporate Secretary
Mr. Anthony D'Adamio
Senior VP & Chief Compliance Officer
Ms. Katrina J. Church J.D.
Show More
Senior VP & Chief Human Resources Officer
Ms. Helen Leupold
Managing Director of China & Asia Pacific
Mr. Larry Chen
Show Less

See Also

Discover More
What is the Intrinsic Value of one BVS stock?

The intrinsic value of one BVS stock under the Base Case scenario is 11.11 USD.

Is BVS stock undervalued or overvalued?

Compared to the current market price of 4.55 USD, Bioventus Inc is Undervalued by 59%.